Category Archives: Events

Latest From Events

International Programming Highlights

international

For those looking to take advantage of all the Convention has to offer, specifically within the international programming, you have landed in the right spot. Take a few minutes to review our international programming highlights. For more information, visit myBIO and map your day out! International Programming Highlights –MONDAY Global Biotechnology Forum: The BRICs and Beyond 10:00 – 11:30 a.m., Room 259 B The Global Biotechnology Forum: The BRICs and Beyond will explore how governments Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , ,

2012 BIO International Convention: Exploring Massachusetts

Bob Coughlin

By Bob Coughlin, President & CEO, MassBio Of course the 2012 BIO International Convention will be a great chance to connect, partner, network and learn. And convention-goers will have the chance to check out Boston’s Innovation District, which surrounds the Convention Center. But why not take some time while you’re in the Boston area to explore the biotech clusters outside metro Boston? There’s something for everyone here in Massachusetts! Head North of the City… The Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , ,

Industry Regulatory Issues to be Highlighted at 2012 BIO International Convention

bio-session

In the words of BIO’s Andrew Emmett, Managing Director, Science & Regulatory Affairs, ‘2012 is shaping up to be a momentous year for FDA reform.’ From the reauthorization of the Prescription Drug User Fee Act (PDUFA V) to modernizing and expediting the approval of new drugs and biologics, implementing the new biosimilars pathways and addressing the growing global drug shortage crisis, all eyes are on the current regulatory environment and its role in supporting innovation. Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Patent-Eligible Subject Matter after Mayo v. Prometheus: Exploring the Path Forward

gw-law

Patent-Eligible Subject Matter after Mayo v. Prometheus: Exploring the Path Forward is a public round-table event hosted by the Biotechnology Industry Organization and the George Washington University Law School. Guest speakers at the round-table will discuss implementation of the Prometheus decision in patent prosecution practice, in examination guidance in the United States Patent Office, and in patent litigation.  Speakers will also discuss the implications of the decision on personalized medicine and possible ways forward.  Speakers include: The Hon. Paul Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , ,

2012 Orphan Disease Forum: Addressing Today’s Opportunities and Challenges

disease

If all of the people with rare disease lived in one country, it would be the world’s third most populous country! Through dedicated companies such as the National Organization for Rare Disorders (NORD) and Centric Health Resources, the pressing issue of orphan diseases and its patients are being addressed. A rare disease is defined by any disease affecting fewer than 200,000 Americans. There are nearly 7,000 such diseases affecting over 350 million people worldwide.  Furthermore, Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , ,